{
  "module": "kr-companies",
  "itemId": "00101664",
  "title": "KYONGBO PHARMACEUTICAL CO., LTD. ((주)경보제약) — KOSPI 214390",
  "summary": "KYONGBO PHARMACEUTICAL CO., LTD. ((주)경보제약, stock code 214390, DART corp_code 00101664) is a KOSPI-listed Korean company. FY2025 (OFS) Revenue: KRW 264,104,056,811.",
  "data": {
    "corp_code": "00101664",
    "stock_code": "214390",
    "name_en": "KYONGBO PHARMACEUTICAL CO., LTD.",
    "name_ko": "(주)경보제약",
    "alternate_names": [
      "경보제약"
    ],
    "market": "KOSPI",
    "ceo_name": "김태영",
    "business_registration_no": "3128104567",
    "corporate_registration_no": "1648110001961",
    "address": "충청남도 아산시 실옥로 174",
    "homepage": "https://www.kbpharma.co.kr/",
    "established_date": "1987-03-31",
    "fiscal_month": "12",
    "industry_code": "211",
    "financials": {
      "fiscal_year": 2025,
      "basis": "OFS",
      "currency": "KRW",
      "revenue": 264104056811,
      "operating_income": 3518577342,
      "net_income": 182293090,
      "total_assets": 319537836305,
      "total_liabilities": 173800165700,
      "total_equity": 145737670605,
      "prior_year": {
        "fiscal_year": 2024,
        "revenue": 238556125924,
        "operating_income": 10453728086,
        "net_income": 4639325809,
        "total_assets": 283886655960,
        "total_liabilities": 137732634119,
        "total_equity": 146154021841
      },
      "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001475",
      "verified_at": "2026-11-01T02:28:08.801Z"
    },
    "recent_filings": [
      {
        "receipt_no": "20261030800523",
        "filed_date": "2026-10-30",
        "title_ko": "영업(잠정)실적(공정공시)",
        "title_en": "Interim Report on Business Performance (Fair Disclosure)",
        "filer": "경보제약",
        "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800523"
      },
      {
        "receipt_no": "20260930000336",
        "filed_date": "2026-09-30",
        "title_ko": "[기재정정]주요사항보고서(영업정지)",
        "title_en": "[Corrected description]Report on business suspension",
        "filer": "경보제약",
        "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260930000336"
      },
      {
        "receipt_no": "20260831001253",
        "filed_date": "2026-08-31",
        "title_ko": "[기재정정]주요사항보고서(영업정지)",
        "title_en": "[Corrected description]Report on business suspension",
        "filer": "경보제약",
        "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260831001253"
      },
      {
        "receipt_no": "20260814003323",
        "filed_date": "2026-08-14",
        "title_ko": "반기보고서 (2026.06)",
        "title_en": "Semi-annual Report (2026.06)",
        "filer": "경보제약",
        "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814003323"
      }
    ],
    "source_urls": {
      "company": "https://dart.fss.or.kr",
      "financials": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001475",
      "filings": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800523"
    },
    "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001475",
    "verified_at": "2026-11-01T08:15:57.572Z",
    "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company."
  },
  "source_url": "https://dart.fss.or.kr",
  "verified_at": "2026-11-01T08:15:57.572Z",
  "updated_at": "2026-11-01T08:15:57.572Z",
  "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company."
}